Bionime Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bionime with three other companies in this sector in Taiwan: Apex Biotechnology Corporation (2016 sales of 1.76 billion Taiwanese Dollars [US$58.15 million] ), OK Biotech Co Ltd (1.04 billion Taiwanese Dollars [US$34.31 million] of which 100% was Ok Biotech Co Ltd), and Cowealth Medical Holding Co Ltd (2.97 billion Taiwanese Dollars [US$97.80 million] of which 93% was Depar. B(Sale Reagent&Other)).

Sales Analysis. During the year ended December of 2016, sales at Bionime were 1.74 billion Taiwanese Dollars (US$57.40 million). This is an increase of 8.1% versus 2015, when the company's sales were 1.61 billion Taiwanese Dollars.